Form 8-K - Current report:
SEC Accession No. 0000318306-14-000037
Filing Date
2014-10-24
Accepted
2014-10-24 09:04:51
Documents
2
Period of Report
2014-10-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K r8k-535.htm 8-K 24469
2 PRESS RELEASE DATED OCTOBER 24, 2014 ex_99-1.htm EX-99.1 9332
  Complete submission text file 0000318306-14-000037.txt   35214
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 141171235
SIC: 2834 Pharmaceutical Preparations